Bioneer, a leader in molecular science, has unveiled its new product, CosmeRNA ARI Intensive Anti-Hair Loss Tonic, offering a breakthrough solution for those affected by androgenetic alopecia (AGA). This innovative cosmetic formulation targets the androgen receptor pathway in hair follicles without altering hormone levels, providing a non-invasive alternative to traditional treatments, which often come with unwanted side effects.
Since its founding in 1992, Bioneer has pioneered advancements in RNA and DNA synthesis. Now, the company is applying this expertise to hair care, addressing the root causes of AGA. The key ingredient in CosmeRNA, SAMiRNA-AR68, works directly with androgen receptors to improve the appearance of thinning hair and restore its vitality.
AGA is caused by dihydrotestosterone (DHT), a hormone that binds to androgen receptors in hair follicles, causing them to shrink and leading to hair loss. While both men and women are affected, women may experience additional sensitivity in these receptors, making them more vulnerable to hair thinning. Traditional treatments that target DHT often disrupt hormonal balance, but CosmeRNA offers a solution that avoids this issue.
Dr. Han-Oh Park, Bioneer’s founder and CEO, explains, “CosmeRNA ARI offers a scientifically-backed approach to improving hair health by gently targeting androgen receptor sensitivity. This method not only delivers visible results but ensures a non-invasive experience that prioritizes comfort and safety.”
With its innovative, non-hormonal approach, CosmeRNA is set to revolutionize the treatment of hair loss, providing a promising option for those seeking a safer, more effective solution for AGA.
Related topics:
- Breaking Barriers: The Founder of Charlotte’s First Black-Owned Curly Hair Salon
- Lush Hair Nigeria Redefines African Beauty at Lagos Fashion Week 2024
- Olivia McVeigh Honoured in BBC 100 Women 2024 List for Alopecia Advocacy
